Panbio Launches New Product: EBV VCA-M One Panbio announces the Australian release of the EBV VCA M-One ELISA for the detection of IgM antibodies to viral capsid antigen (VCA) in serum. The product incorporates a single serum dilution step and room temperature incubations making it highly suitable for adaptation to automated ELISA instruments. Read more or visit the Panbio product page to download IFU and poster from 24th NRL Workshop on Serology.
First Patent Application for Homogeneous Assay technology Panbio's Advanced Technologies team have filed their first patent application for the panDA Homogeneous Assay Technology. "We now have a package to offer and can discuss the platform more openly with potential licensees and partners," said Acting CEO Dr Stuart Hazell. Read more... To view an animation illustrating the Homogeneous Assay concept click here.
Dengue Early ELISA: a new age in dengue diagnostics Panbio, the world leader in dengue diagnostics, announces the release of the Dengue Early ELISA. The Dengue Early ELISA is a dengue NS1 antigen capture ELISA and is used as an aid in the clinical laboratory diagnosis of acute, active dengue infection. Read more.....
Technical Bulletin: Calibration Factor to be Introduced to Panbio ELISA assays As part of our continuous improvement process, all ELISA assays manufactured by Panbio will have a Calibration Factor*. Read More... *Except West Nile Virus IgM ELISA
Commerciaizing your IP? Panbio would like to hear from you.  Click here to read more.